Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP1LC3B | Q9GZQ8 | 7/20 | 0.43 |
| ▸ | CARM1 | Q86X55 | 5/20 | 0.38 |
| ▸ | PRMT6 | Q96LA8 | 5/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26523495 | 0.86 | MAP1LC3B (0.47) | MAP1LC3BLMNAMAPTCYP3A4CYP2C9 | |
| SCHEMBL21821804 | 0.85 | MAP1LC3B (0.46) | MAP1LC3BLMNAMAPTCYP3A4CYP2C9 | |
| SCHEMBL21821814 | 0.84 | MAP1LC3B (0.45) | MAP1LC3BLMNAMAPTCYP3A4CYP2C9 | |
| SCHEMBL21821944 | 0.84 | MAP1LC3B (0.57) | MAP1LC3BLMNAMAPTCYP3A4CYP2C9 | |
| SCHEMBL21821686 | 0.83 | MAP1LC3B (0.44) | MAP1LC3BLMNAMAPTCYP3A4CYP2C9 | |
| SCHEMBL21821609 | 0.82 | MAP1LC3B (0.48) | MAP1LC3BLMNAMAPTCYP3A4CYP2C9 | |
| SCHEMBL22111647 | 0.82 | MAP1LC3B (0.43) | MAP1LC3BLMNATLR9MAPTCYP3A4 | |
| SCHEMBL21821876 | 0.80 | MAP1LC3B (0.43) | MAP1LC3BLMNAMAPTCYP3A4CYP2C9 | |
| SCHEMBL21821800 | 0.80 | L3MBTL1 (0.47) | MAP1LC3BL3MBTL1TSHRMEN1KMT2A | |
| SCHEMBL21821705 | 0.80 | MAP1LC3B (0.43) | MAP1LC3BLMNAMAPTCYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11319303-B2 | Compound used as autophagy regulator, and preparation method therefor and uses thereof | Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) | 2022-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11319303-B2 | Compound used as autophagy regulator, and preparation method therefor and uses thereof | ATG7, SQSTM1, BECN1 | MAP1LC3B 15/4885CARM1 2361/4885PRMT6 3234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.